Cambrex | Sustainability Performance
Offers contract development and manufacturing services for small molecule therapeutics, providing active pharmaceutical ingredients and finished dosage forms.
1981
United States
1,001 - 5,000 employees
Pharmaceuticals
$500M - 1B in revenue
Not profitable
Submit or report inaccurate dataDownload Company InsightsⓘBy downloading this report, you'll receive the most insightful and detailed analysis of the company's sustainability performance, compared to its peers. It includes key industry trends, carbon and energy intensity, nature impact, social metrics, and an in-depth look at key risks and controversies.
Sustainability Ranking & Industry Benchmark
#8032
Overallⓘ#1866
in United Statesⓘ#191
in PharmaceuticalsⓘSustainability Maturity
ⓘSustainability Intent
ⓘOverview
Controversy level
- Cambrex's pharmaceutical contract manufacturing operations face FDA Form 483 observations and quality compliance scrutiny at multiple US and European facilities affecting client production schedules.
Sustainability employees
ⓘWe follow the strictest rules to ensure compliance with all the relevant data protection laws, including GDPR. Click here for our Privacy Policy.Total sustainability employees
4-6
ⓘThis value represents the estimated number of employees in a company with sustainability-related roles or job titles, as determined by Illuminem using publicly available data.